Inventor · disambiguated record
Sarah M. Cheal
Also filed as: CHEAL SARAH · CHEAL SARAH M
6 granted patents·6 pending applications·13 citations·filing 2004–2024
73Inventor score
Top patents by PatentIndex Score
12 records- 0183US10988534B2Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Apr 27, 2021·2 cites·16 claims
- 0278US11565005B2Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jan 31, 2023·1 cites·23 claims
- 0375US2025345466A1Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0469US11858993B2Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Jan 2, 2024·0 cites·3 claims
- 0567US7267994B2Element-coded affinity tagsUNIV CALIFORNIA·Filed 2004·Granted Sep 11, 2007·10 cites·27 claims
- 0654US11413354B2N-acetylgalactosamino dendron-clearing agent for dota-pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Aug 16, 2022·0 cites·20 claims
- 0751US2023346988A1Systems for in vivo monitoring of immune cells in patients undergoing cellular immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 0851US2024026037A1Anti-gpa33 multi-specific antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 0950US2023256121A1Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1050US2023348853A1C825 expressing immune cells and diagnostic uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1149US2021017295A1Bispecific binding agents and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 1233US10806808B2Systems and methods for determining optimum patient-specific antibody dose for tumor targetingMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Oct 20, 2020·0 cites·53 claims
Join the waitlist — get patent alerts
Get an alert when Sarah M. Cheal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →